These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 10491849)
1. QSAR studies of antiviral agents using molecular similarity analysis and structure-activity maps. Parakulam RR; Lesniewski ML; Taylor-McCabe KJ; Tsai C SAR QSAR Environ Res; 1999; 10(2-3):175-206. PubMed ID: 10491849 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and anti-HIV activity of 4'-modified cyclopentenyl pyrimidine C-nucleosides. Liu LJ; Hong JH Nucleosides Nucleotides Nucleic Acids; 2009 Apr; 28(4):303-14. PubMed ID: 20183583 [TBL] [Abstract][Full Text] [Related]
3. In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives. Vilar S; Estrada E; Uriarte E; Santana L; Gutierrez Y J Chem Inf Model; 2005; 45(2):502-14. PubMed ID: 15807516 [TBL] [Abstract][Full Text] [Related]
4. Neural networks: Accurate nonlinear QSAR model for HEPT derivatives. Douali L; Villemin D; Cherqaoui D J Chem Inf Comput Sci; 2003; 43(4):1200-7. PubMed ID: 12870912 [TBL] [Abstract][Full Text] [Related]
5. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis. Debnath AK J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730 [TBL] [Abstract][Full Text] [Related]
6. Simple synthesis and anti-HIV activity of novel 3'-vinyl branched apiosyl pyrimidine nucleosides. Oh CH; Kim JW; Hong JH Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):871-8. PubMed ID: 16901819 [TBL] [Abstract][Full Text] [Related]
7. 5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity. El Safadi Y; Paillart JC; Laumond G; Aubertin AM; Burger A; Marquet R; Vivet-Boudou V J Med Chem; 2010 Feb; 53(4):1534-45. PubMed ID: 20112915 [TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship studies on 1-aryl-tetrahydroisoquinoline analogs as active anti-HIV agents. Chen KX; Xie HY; Li ZG; Gao JR Bioorg Med Chem Lett; 2008 Oct; 18(20):5381-6. PubMed ID: 18835162 [TBL] [Abstract][Full Text] [Related]
9. Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase. Sun J; Cai S; Mei H; Li J; Yan N; Wang Q; Lin Z; Huo D Chem Biol Drug Des; 2010 Sep; 76(3):245-54. PubMed ID: 20626407 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationship studies of TIBO derivatives using support vector machines. Darnag R; Schmitzer A; Belmiloud Y; Villemin D; Jarid A; Chait A; Mazouz E; Cherqaoui D SAR QSAR Environ Res; 2010 Apr; 21(3-4):231-46. PubMed ID: 20544549 [TBL] [Abstract][Full Text] [Related]
11. Linear indices of the "molecular pseudograph's atom adjacency matrix": definition, significance-interpretation, and application to QSAR analysis of flavone derivatives as HIV-1 integrase inhibitors. Marrero-Ponce Y J Chem Inf Comput Sci; 2004; 44(6):2010-26. PubMed ID: 15554670 [TBL] [Abstract][Full Text] [Related]
12. Structure-based identification of small molecule antiviral compounds targeted to the gp41 core structure of the human immunodeficiency virus type 1. Debnath AK; Radigan L; Jiang S J Med Chem; 1999 Aug; 42(17):3203-9. PubMed ID: 10464007 [TBL] [Abstract][Full Text] [Related]
13. QSAR study on some anti-HIV HEPT analogues using physicochemical and topological parameters. Gayen S; Debnath B; Samanta S; Jha T Bioorg Med Chem; 2004 Mar; 12(6):1493-503. PubMed ID: 15018923 [TBL] [Abstract][Full Text] [Related]
14. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors. Teixeira C; Serradji N; Maurel F; Barbault F Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues. Bell TW; Anugu S; Bailey P; Catalano VJ; Dey K; Drew MG; Duffy NH; Jin Q; Samala MF; Sodoma A; Welch WH; Schols D; Vermeire K J Med Chem; 2006 Feb; 49(4):1291-312. PubMed ID: 16480266 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral screening of some thieno[2,3-d]pyrimidine nucleosides. Rashad AE; Ali MA Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):17-28. PubMed ID: 16440982 [TBL] [Abstract][Full Text] [Related]
17. Nucleosides and nucleotides. 185. Synthesis and biological activities of 4'alpha-C-branched-chain sugar pyrimidine nucleosides. Nomura M; Shuto S; Tanaka M; Sasaki T; Mori S; Shigeta S; Matsuda A J Med Chem; 1999 Jul; 42(15):2901-8. PubMed ID: 10425099 [TBL] [Abstract][Full Text] [Related]
19. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024 [TBL] [Abstract][Full Text] [Related]
20. A 3D QSAR study of a series of HEPT analogues: the influence of conformational mobility on HIV-1 reverse transcriptase inhibition. Kireev DB; Chrétien JR; Grierson DS; Monneret C J Med Chem; 1997 Dec; 40(26):4257-64. PubMed ID: 9435895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]